ArticleFarmaceuticos comunitarios2026
Social Marketing Strategies in the Pharmaceutical Industry, Characteristics and Impact; a scoping review.
Article in Farmaceuticos comunitarios, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To describe the social marketing strategies implemented by the pharmaceutical industry and their potential impact on consumer behavior and access to medicines, through a scoping review. Methods: A scoping review was conducted following the PRISMA-ScR guidelines. For data collection, scientific articles published between 2006 and 2025 in English and Spanish were selected using the PCC criteria (Population, Concept, Context), which are recommended for this type of research. The databases consulted were SciELO, Google Scholar, and PubMed. Articles published in peer-reviewed academic journals were included if their title, abstract, or keywords contained at least one of the descriptors used in the search equation. Results: Four categories of analysis emerged: 1) marketing and positioning, 2) corporate social responsibility, communication, and ethics, 3) digital transformation and innovation, and 4) pharmacy and access to medicines. A critical inflection point was identified, highlighting the intersection of access to medicines with the role of community pharmacies, which are implementing strategies to balance social commitments with commercial objectives. Conclusions: The pharmaceutical industry's social marketing strategies can be multidimensional. They have evolved from traditional corporate positioning to emerging categories that integrate ethics, digital transformation, and public health innovation. The current challenge lies in balancing business viability with the population's health and social needs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.